Ursprung des Netzwerks ersten Grades von Hans-Juergen Woerle
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France.
12
| Holding Company | Pharmaceuticals: Major | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hans-Juergen Woerle
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Founder | |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
NATUREX | Food: Specialty/Candy | Director/Board Member | |
Laboratoires Fournier SAS
Laboratoires Fournier SAS Pharmaceuticals: MajorHealth Technology Laboratoires Fournier SAS manufactures pharmaceutical preparations. The company was founded on July 10, 2007 and is headquartered in Rungis, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
DIMENSION THERAPEUTICS INC | Biotechnology | Director/Board Member Director of Finance/CFO | |
MAAT PHARMA | Pharmaceuticals: Major | Director/Board Member Founder | |
Polaris SA /FR/
Polaris SA /FR/ Pharmaceuticals: MajorHealth Technology Polaris SA engages in the biotechnology industry and specializes in the field of healthy omega 3 lipids. The company was founded by St?phane Lozachmeur and Gildas Breton on July 1, 1994 and is headquartered in Quimper, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
LiMM Therapeutics SA
LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Financial Conglomerates | Director/Board Member | |
TargEDys SA
TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Biotechnology | Director/Board Member | |
BIOPHYTIS S.A. | Pharmaceuticals: Other | Director/Board Member | |
Pfizer, Inc. /Angers & Val-de-Reuil Pharmaceutical Operations | Pharmaceuticals: Major | Corporate Officer/Principal | |
École Centrale Paris | College/University | Undergraduate Degree | |
Vivostat A/S
Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Medical Specialties | Director/Board Member | |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Chief Executive Officer | |
IO BIOTECH, INC. | Biotechnology | Chairman | |
ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
TRex Bio Ltd.
TRex Bio Ltd. BiotechnologyHealth Technology TRex Bio Ltd. is a British company that provides biotechnology research and development services. The private company is based in London, UK. The company was founded in 2018 by Houman Ashrafian. | Biotechnology | Director/Board Member | |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman | |
VAXCYTE, INC. | Biotechnology | Director/Board Member | |
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Biotechnology | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Bain & Co., Inc. (London)
Bain & Co., Inc. (London) Miscellaneous Commercial ServicesCommercial Services Founded in 1985, Part of Bain & Co., Inc., Bain & Co., Inc. (London) is a British company that provides management consultancy services. The company is based in London, UK. | Miscellaneous Commercial Services | Private Equity Analyst | |
L Catterton Asia (Shanghai Office) | Investment Managers | Corporate Officer/Principal | |
Rocket Internet /Venture Capital/
Rocket Internet /Venture Capital/ Investment ManagersFinance Rocket Internet is the venture capital division of Rocket Internet SE founded in 2007 by the Samwer brothers Marc, Alexander, and Oliver. The firm is headquartered in Berlin, Germany. | Investment Managers | Director of Research - Equity | |
GLOBAL FASHION GROUP S.A. | Apparel/Footwear Retail | Corporate Officer/Principal | |
Finery London | Founder | ||
StoryCenter
StoryCenter Internet Software/ServicesTechnology Services StoryCenter is a project that has developed a resource for families to use as they explore how best to support their trans and nonbinary young people in a divisive climate where laws banning gender-affirming care and appropriate health services for trans and nonbinary youth have been proposed and passed in numerous red states. The project aims to create supportive family and community environments where young people can explore and express their transness. Additionally, the Kennedy-Lugar Youth Exchange and Study (YES) program through the U.S. Department of State is established to foster human understanding and open, sustainable relationships across cultures by inviting high school students from countries with significant Muslim populations to live with a host family for an academic year. | Internet Software/Services | Corporate Officer/Principal | |
Direct Ferries Ltd.
Direct Ferries Ltd. Marine ShippingTransportation Direct Ferries Ltd. provides ferry ticketing service. The firm is a multi-platform impartial ferry ticketing service offering a way to look, compare, and book scheduled ferry crossings to virtually any ferry port in Europe. The company was founded by Howard John Davies in 1999 and is headquartered in London, the United Kingdom. | Marine Shipping | Corporate Officer/Principal | |
Definitive Capital Management LP
Definitive Capital Management LP Investment ManagersFinance Founded in 2010, Definitive Capital Management LP is a hedge fund manager located in Radnor, Pennsylvania. The firm manages the Definitive Guardian Fund Ltd. (formerly the Vision Guardian Fund Ltd.) and the Definitive Guardian Partners LP (formerly the Vision Guardian Partners LP). | Investment Managers | Portfolio Manager-Equities | |
Lio Capital Srl
Lio Capital Srl Financial ConglomeratesFinance Lio Capital Srl engages in the provision of investment services. It specializes in special situations and distressed investments. Its activities include purchase of overdue credits from small and medium-sized enterprises (SMEs) operating in the Italian Public Administration sector, selection of distressed mortgage loans, and purchase of mortgage loans at a discount, but lower than the current market value of the collateral. The company was founded in 2012 and is headquartered in Milan, Italy. | Financial Conglomerates | Private Equity Investor | |
Xyence Capital SGR
Xyence Capital SGR Investment ManagersFinance Xyence Capital SGR (Xyence Capital) is a venture capital firm founded in 2002 by Stefano Peroncini and Pierluigi Paracchi. The firm is headquartered in Milano, Italy. | Investment Managers | Chief Executive Officer | |
AB SCIENCE | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer |
Statistik
International
Frankreich | 17 |
Vereinigte Staaten | 14 |
Dänemark | 5 |
Vereinigtes Königreich | 5 |
Italien | 3 |
Sektoral
Health Technology | 28 |
Finance | 8 |
Commercial Services | 6 |
Consumer Services | 3 |
Consumer Non-Durables | 2 |
Operativ
Director/Board Member | 70 |
Corporate Officer/Principal | 40 |
Independent Dir/Board Member | 20 |
Chairman | 17 |
Chief Executive Officer | 11 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Hans-Juergen Woerle
- Unternehmensverbindungen